Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BENNOUNA, Jaafar")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 32

  • Page / 2
Export

Selection :

  • and

Les cancers du poumon à petites cellules = Small cell lung carcinomaBENNOUNA, Jaafar; DOUILLARD, Jean-Yves.Concours médical (Paris). 2002, Vol 124, Num 29, pp 1889-1893, issn 0010-5309, 5 p.Article

L'apport du blocage continu de l'angiogenèse dans le traitement des cancers colorectaux métastatiques (CCRm): introduction au concept de maintenance au-delà de la progression = The contribution of a sustained angiogenesis inhibition in metastatic colorectal cancer (mCCR) treatment. Introduction to maintenance concept beyond progressionBENNOUNA, Jaafar; ANDRE, Thierry.Hépato-gastro & oncologie digestive. 2012, Vol 19, Num 7, pp 526-533, issn 2115-3310, 8 p.Article

Les essais thérapeutiques PRODIGE en cours = PRODIGE ongoing trialsMANFREDI, Sylvain; MICHEL, Pierre; ADENIS, Antoine et al.La Lettre du cancérologue (Boulogne). 2013, Vol 22, Num 6, pp 234-237, issn 1165-113X, 4 p.Conference Paper

Les essais thérapeutique PRODIGE en cours = PRODIGE ongoing trialsMANFREDI, Sylvain; MICHEL, Pierre; ADENIS, Antoine et al.La Lettre de l'hépato-gastroentérologue. 2013, Vol 16, Num 2, pp 74-77, issn 1286-580X, 4 p.Conference Paper

The Role of UFT in Metastatic Colorectal CancerBENNOUNA, Jaafar; SAUNDERS, Mark; DOUILLARD, Jean-Yves et al.Oncology. 2009, Vol 76, Num 5, pp 301-310, issn 0030-2414, 10 p.Article

Vinflunine : A New Microtubule Inhibitor Agent : The development of new cytotoxic agents in clinical oncologyBENNOUNA, Jaafar; DELORD, Jean-Pierre; CAMPONE, Mario et al.Clinical cancer research. 2008, Vol 14, Num 6, pp 1625-1632, issn 1078-0432, 8 p.Article

Small cell carcinoma of the esophagus: Analysis of 10 cases and review of the published dataBENNOUNA, Jaafar; BARDET, Etienne; DEGUIRAL, Philippe et al.American journal of clinical oncology. 2000, Vol 23, Num 5, pp 455-459, issn 0277-3732Article

Cancer bronchique primitifSENELLART, Hélène; NAUDIN, Frédérique; BEDEL, Anne-Laure et al.La Revue du praticien. Médecine générale. 2009, Num 815, pp 89-93, issn 0989-2737, 5 p.Article

Place des traitements d'entretien et de la pause thérapeutique complète dans la prise en charge des cancers colorectaux métastatiques non résécables = Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancerSENELLART, Hélène; HIRET, Sandrine; GUERIN-MEYER, Véronique et al.Bulletin du cancer. 2014, Vol 101, Num 6, pp 619-625, issn 0007-4551, 7 p.Article

Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trialBENNOUNA, Jaafar; SENELLART, Helene; HIRET, Sandrine et al.Lung cancer. 2011, Vol 74, Num 1, pp 30-34, issn 0169-5002, 5 p.Article

Les premières lignes de traitement dans les cancers colorectaux métastatiques (CCRm): la meilleure option pour une stratégie multi-lignes préférentielle = First-line treatments in metastatic colorectal cancer (mCRC): the best option for a preferential multilines strategyBENNOUNA, Jaafar; HIRET, Sandrine; SENELLART, Hélène et al.Hépato-gastro (Montrouge). 2011, Vol 18, issn 1253-7020, S3-S12, SUP5Article

Vinflunine Oral Pharmacokinetics and Absolute Bioavailability of Soft and Hard Gelatin Capsules: Results of Two Phase I TrialsDELORD, Jean-Pierre; BENNOUNA, Jaafar; MOUREY, Loïc et al.Clinical pharmacokinetics. 2012, Vol 51, Num 6, pp 357-364, issn 0312-5963, 8 p.Article

Repeat hepatectomy for colorectal liver metastasesHAMY, Antoine; BENNOUNA, Jaafar; HEYMANN, Marie-Francoise et al.International surgery. 2005, Vol 90, Num 4, pp 189-197, issn 0020-8868, 9 p.Article

Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responsesBENNOUNA, Jaafar; HILDESHEIM, Allan; CHIKAMATSU, Kazuaki et al.Journal of immunological methods. 2002, Vol 261, Num 1-2, pp 145-156, issn 0022-1759Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Nouvelle perspective de traitement dans le cancer bronchique non à petites cellules (CBNPC). Place de l'afatinib: un inhibiteur oral et irréversible de la famille ErbB = A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blockerWISLEZ, Marie; MALKA, David; BENNOUNA, Jaafar et al.Bulletin du cancer. 2014, Vol 101, Num 6, pp 647-651, issn 0007-4551, 5 p.Article

Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patientsCAMPONE, Mario; RADEMAKER-LAKHAI, Jeany M; BENNOUNA, Jaafar et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 4, pp 523-533, issn 0344-5704, 11 p.Article

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trialQUOIX, Elisabeth; ZALCMAN, Gerard; DANSIN, Eric et al.Lancet (British edition). 2011, Vol 378, Num 9796, pp 1079-1088, issn 0140-6736, 10 p.Article

Phase-I study of Innacell γδTM, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinomaBENNOUNA, Jaafar; BOMPAS, Emmanuelle; LAFAYE-DE MICHEAUX, Sylvie et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 11, pp 1599-1609, issn 0340-7004, 11 p.Article

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR MutationsSEQUIST, Lecia V; YANG, James Chih-Hsin; SU, Wu-Chou et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3327-3334, issn 0732-183X, 8 p.Article

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non―Small-Cell Lung CancerPAZ-ARES, Luis G; BIESMA, Bonne; SYRIGOS, Kostas et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3084-3092, issn 0732-183X, 9 p.Article

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumorsBENNOUNA, Jaafar; LEVY, Vincent; TIOLLIER, Jérome et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1521-1530, issn 0340-7004, 10 p.Article

DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane―platinum regimen as first-line therapy for metastatic non-small cell lung cancerVON PAWEL, Joachim; GORBOUNOVA, Vera; RECK, Martin et al.Lung cancer. 2014, Vol 85, Num 2, pp 224-229, issn 0169-5002, 6 p.Article

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Federation Francophone de Cancérologie Digestive 9902 phase II randomised studyPHELIP, Jean-Marc; VENDRELY, Véronique; FAUCHART, Jean-Pierre et al.European journal of cancer (1990). 2014, Vol 50, Num 17, pp 2975-2982, issn 0959-8049, 8 p.Article

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non―Small-Cell Lung Cancer: A Randomized, Controlled Phase III TrialRAMLAU, Rodryg; GORBUNOVA, Vera; REY, Augustin et al.Journal of clinical oncology. 2012, Vol 30, Num 29, pp 3640-3647, issn 0732-183X, 8 p.Article

  • Page / 2